| Literature DB >> 27927070 |
Javier Morales-López1, Mónica Centeno-Álvarez2, Antonio Nieto-Camacho3, Mercedes G López4, Elizabeth Pérez-Hernández5, Nury Pérez-Hernández1, Eduardo Fernández-Martínez6.
Abstract
CONTEXT: There have been no reports of the extraction of essential oil (EO) from white cabbage [Brassica oleracea L. var. capitata (L.) Alef. f. alba DC. (Brassicaceae)] (Bocfal) or its chemical composition, antioxidant activity, or hepatoprotective effects.Entities:
Keywords: Brassica oleracea var. capitata f. alba; hepatoprotection; organic polysulphides
Mesh:
Substances:
Year: 2017 PMID: 27927070 PMCID: PMC6130702 DOI: 10.1080/13880209.2016.1258424
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Major components of B. oleracea var. capitata F. alba essential oil (Bocfal EO) obtained by hydrodistillation at low pressure (200–150 mmHg) and low temperature (55–58 °C) conditions.
| Peak(#) | RT (Min) | RI | Compound | Content (%) |
|---|---|---|---|---|
| (1) | 2.26 | 1224 | Dimethyl disulphide (DMDS) | 19.29 ± 2.16 |
| (11) | 6.24 | 1544 | Dimethyl trisulphide (DMTS) | 65.43 ± 4.92 |
| (13) | 7.12 | 1595 | Methyl pentyl disulphide | 0.19 ± 0.04 |
| (17) | 10.07 | 1750 | Allyl methyl trisulphide | 0.22 ± 0.07 |
| (19) | 11.39 | 1818 | Methyl methylthiomethyl disulphide | 1.39 ± 0.24 |
| (20) | 12.89 | 1893 | Dimethyl tetrasulphide | 1.50 ± 1.01 |
| (10) | 5.94 | 1527 | Allyl isothiocyanate (AITC) | 4.31 ± 0.70 |
| (14) | 7.59 | 1621 | 3-Butenyl isothiocyanate | 0.85 ± 0.16 |
| (22) | 17.64 | 2109 | Indole | 0.10 ± 0.01 |
| (23) | 18.04 | 2125 | 1-Methoxyindole | 0.01 ± 0.00 |
| (24) | 19.38 | 2181 | 3-(Methylthio)propyl isothiocyanate | 0.47 ± 0.13 |
| (26) | 25.62 | 2511 | Butyl isothiocyanate | 0.19 ± 0.05 |
| (28) | 27.67 | 2731 | Phenylethyl isothiocyanate | 0.61 ± 0.15 |
| (3) | 3.21 | 1336 | 3-Butenenitrile | 1.50 ± 0.23 |
| (6) | 4.03 | 1415 | 4-Methylpentanenitrile | 0.16 ± 0.03 |
| (7) | 4.48 | 1441 | 2-Pentenenitrile | 0.41 ± 0.06 |
| (8) | 4.83 | 1462 | Hexanenitrile | 0.14 ± 0.01 |
| (25) | 22.04 | 2352 | Benzene;propanenitrile | 0.08 ± 0.02 |
| (2) | 2.94 | 1306 | Penten-3-ol | 0.51 ± 0.07 |
| (5) | 3.84 | 1404 | 2-Pentenol | 0.23 ± 0.04 |
| (9) | 5.76 | 1516 | 1-Hexanol | 1.32 ± 0.34 |
| (12) | 6.73 | 1556 | 2-Hexen1-ol | 0.39 ± 0.10 |
| (4) | 3.67 | 1388 | 2-Hexenal | 0.30 ± 0.05 |
| (18) | 10.71 | 1783 | Heptanal | 0.07 ± 0.01 |
| (21) | 14.43 | 1970 | 2,4-Decadienal | 0.05 ± 0.02 |
| (15) | 8.00 | 1642 | 3,3-Dimethylallylbromide | 0.23 ± 0.03 |
| (16) | 8.60 | 1673 | Camphor | 0.04 ± 0.01 |
| (27) | 26.93 | 2601 | Eugenol | 0.03 ± 0.02 |
RI: retention index; RT: retention time.
Antioxidant activity by TBARS assay.
| Tested compound | TBARS – IC50 (mg/L) |
|---|---|
| Bocfal EO | 0.51 ± 0.03 |
| DMTS | 3.00 ± 0.2 |
| DMDS | No activity |
| AITC | 3.16 ± 0.13 |
| DADS | 444.64 ± 49.57 |
| BHT | 0.27 ± 0.10 |
| α-Tocopherol | 2.92 ± 0.93 |
Results are expressed as the mean value ± SEM of experiments performed in duplicate with samples of rat brain homogenates from at least five animals.
Different from Bocfal EO, p < 0.05, ANOVA, Dunnett’s test.
Figure 1.Plasma cholestasis markers: enzyme activities of alkaline phosphatase (AP) and γ-glutamyl transpeptidase (GGTP); total bilirubin determined in the plasma from control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.
Figure 2.Plasma and liver markers of necrosis, functionality and oxidative stress: alanine aminotransferase enzyme activity (ALT) determined in the plasma, hepatic levels of lipid peroxidation (LP) and glycogen, and catalase activity (CAT) quantified in the livers of control rats treated with their respective vehicles (VE + VTC), with Bocfal EO (Bocfal EO + VCT) or with DADS (DADS + VCT) as well as those administered the hepatotoxicant CT (VE + CT) but treated with the same compound, respectively (Bocfal EO + CT and DADS + CT). Each bar represents the mean value of experiments performed in duplicate with samples from at least four animals ± SEM. (a) Difference from the VE + VCT group and (b) from the VE + CT group, p < 0.05, Student–Newman–Keuls test.
Figure 3.Haematoxylin/eosin staining of representative liver sections from: (A) normal control rats administered vehicle (VE + VCT); (B) damaged control rats administered CT (VE + CT); (C) control rats administered Bocfal EO (Bocfal EO + VCT); (D) damaged rats administered Bocfal EO (Bocfal EO + CT); (E) control rats administered DADS (DADS + VCT) and (F) damaged rats administered DADS (DADS + CT). Central vein (CV), original magnification: 10×.